Preliminary Study: Rarefied Air Inhalation May Ease Parkinson's Symptoms

A preliminary Unesp study reports that controlled inhalation of rarefied air is safe, does not affect sleep, and helps regulate inflammation markers in Parkinson's patients. Findings are early-stage and not yet peer-reviewed or replicated, so therapeutic efficacy remains unproven. If confirmed, it could open a novel non-pharmacological adjunct for neurodegenerative disease management.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works